Application of chitosan gel in the treatment of chronic periodontitis

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 80, Issue 2, 2007, Pages 290-296

  Akincibay, Hakan ^a   Şenel, Sevda ^a   Ay, Zuhal Yetkin ^a,b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Chitosan; Chitosan gel; Dental craniofacial material; Drug delivery release; Periodontitis

Indexed keywords

ANTIBIOTICS; CONTROLLED DRUG DELIVERY; DENTAL MATERIALS; GELS; PATIENT TREATMENT;

CHITOSAN; CHITOSAN GEL; DRUG DELIVERY; GINGIVAL RECESSION; PERIODONTITIS;

CHITIN;

CHITOSAN; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GEL; GINGIVA; GINGIVA BLEEDING; HUMAN; MALE; PERIODONTITIS; TOOTH PLAQUE; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BIOCOMPATIBLE MATERIALS; CHITOSAN; CHRONIC DISEASE; DENTAL MATERIALS; DRUG CARRIERS; FEMALE; GELS; HUMANS; MALE; MATERIALS TESTING; METRONIDAZOLE; MIDDLE AGED; PERIODONTITIS;

EID: 33847004041     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30596     Document Type: Article

References (60)

1. Zambon JJ. Periodontal diseases: Microbial factors. Ann Periodontol 1996;1:879-925.
2. Cobb CM. Non-surgical pocket therapy: Mechanical. Ann Periodontol 1996;1:443-490.
3. Palcanis KG. Surgical pocket therapy. Ann Periodontol 1996;1:589-617.
4. Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr, Socransky SS. The effect of SRP on the clinical and microbiological parameters of periodontal disease. J Clin Periodontol 1997;24:324-334.
5. Cugini MA, Haffajee AD, Smith C, Kent RL Jr, Socransky SS. The effect of SRP on the clinical and microbiological parameters of periodontal disease: 12-month results. J Clin Periodontol 2000;27:30-36.
6. Kornman KS. Refractory periodontitis: Clinical questions in clinical management. J Clin Periodontol 1996;23:293-298.
7. Haffajee AD, Socransky S. Microbial and etiologic agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
8. Slots J. Position paper: Systemic antibiotics in periodontics. J Periodontol 1996;67:831-838.
9. Mariotti A, Monroe PJ. Pharmacologic management of periodontal diseases using systemically administered agents. Dent Clin North Am 1998;42:245-261.
10. Genco RJ. Antibiotics in the treatment of human periodontal diseases. J Periodontol 1981;52:545-558.
11. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-493.
12. Williams RC, Paquette DW, Offenbacher S, Adams DF, Armitage GC, Bray K, Caton J, Cochran DL, Drisko CH, Fiorellini JP, Giannobile WV, Grossi S, Guerrero DM, Johnson GK, Lamster IB, Magnusson I, Oringer RJ, Persson GR, Van Dyke TE, Wolff LF, Santucci EA, Rodda BE, Larsen J. Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial. J Periodontol 2001;72:1535-1544.
13. Van Steenberghe D, Rosling B, Söder PÖ, Landry RG, van der Velden U, Timmerman MFT, McCarthy EF, Wouters C. A 15-month evaluation of the effects of repeated minocycline in chronic adult periodontitis. J Periodontol 1999;70:657-667.
14. Friesen LR, Williams KB, Krause LS, Killoy WJ. Controlled local delivery of tetracycline with polymer strips in the treatment of periodontitis. J Periodontol 2002;73:13-19.
15. Wolinsky LE, Camargo PM, Polson A, Ryder M, Garrett S. The significance of prior mechanical therapy for changes of periodontal status achieved by local delivery of a doxycycline-hyclate containing gel. J Clin Periodontol 2001;28:1115-1120.
16. Wennström JL, Newman HN, Mac Neill SR, Killoy WS, Griffits GS, Gillam DG, Krok L, Needleman IG. Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. J Clin Periodontol 2001;28:753-761.
17. Grisi DC, Salvador SL, Figueiredo LC, Souza SLS, Novaes AB Jr, Grisi MFM. Effect of a controlled release chlorhexidine chip on clinical and microbiological parameters of periodontal syndrome. J Clin Periodontol 2002;29:875-881.
18. Jeffcoat MK, Palcanis KG, Weatherford TW, Reese M, Geurs NC, Flashner M. Use of biodegradable chlorhexidine chip in the treatment of adult periodontitis: Clinical and radiographic findings. J Periodontol 2000;71:256-262.
19. Griffiths GS, Smart GJ, Bulman JS, Weiss G, Schrowder J, Newman HN. Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel. J Clin Periodontol 2000;27:910-917.
20. Mombelli AW, van Winkelhoff AJ. The systemic use of antibiotics in periodontal therapy. In: Lang NP, Karring T, Lindhe J, editors. Proceedings of the second European Workshop on Periodontology. Berlin: Quintessence Verlag; 1996. pp 38-77.
21. Preus HR, Lassen J, Aass AM, Ciancio SG. Bacterial resistance following subgingival and systemic administration of minocycline. J Clin Periodontol 1995;22:380-384.
22. Greenstein G, Tonetti M. Position paper: The role of controlled drug delivery for periodontitis. J Periodontol 2000;71:125-140.
23. Minsk L. Locally delivered antibiotics in periodontics. Compendium 2001;22:748-755.
24. Needleman IG, Martin GP, Smales FC. Characterization of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol 1998;25:74-82.
25. Langer R. New methods of drug delivery. Science 1990;249:1527-1533.
26. Needleman IG, Smales FC, Martin GP. An investigation of bioadhesion for mucosal and oral mucosal drug delivery. J Clin Periodontol 1997;24:394-400.
27. Felt O, Buri P, Gurny R. Chitosan: A unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998;24:979-993.
28. İkinci G, Şenel S, Akincibay H, Kaş S, Erciş S, Wilson CG, Hincal AA. Effect of chitosan on a periodontal pathogen: Porphyromonas gingivalis. Int J Pharm 2002;255:121-127.
29. Jumaa M, Furkert FH, Müler BW. A new emulsion formulation with antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 2002;53:115-123.
30. Kim KW, Thomas RL, Lee C, Park HJ. Antimicrobial activity of native chitosan, degraded chitosan, and o-carboxymetylated chitosan. J Food Prot 2003;66:1495-1498.
31. Muzzarelli RAA, Baldassare V, Conti F, Ferrara P, Biagini G, Gazzanelli G, Vasi V. Biological activity of chitosan: Ultrastructural study. Biomaterials 1988;9:247-252.
32. Biagini G, Bertani A, Muzzarelli RAA, Damadei A, Dibenedetto G, Belligolli A, Riccotti G, Zucchini C, Rizzolli C. Wound management with n-carboxybutyl chitosan. Biomaterials 1991;12:281-286.
33. Klokkevold PR, Lew DS, Ellis DG, Bertolami CN. Effect of chitosan on lingual hemostasis in rabbits. J Oral Maxillofac Surg 1991;49:858-863.
34. Risbud M, Hardikar A, Bhonde R. Growth modulation of fibroblasts by chitosan-polyvinyl pyrrolidone hydrogel: Implications for wound management. J Biosci 2000;25:25-31.
35. Klokkevold PR, Vandemark L, Kenney EB, Bernard GW. Osteogenesis enhanced by chitosan (poly-n-acetyl glucosaminoglycan) in vitro. J Periodontol 1996;67:1170-1175.
36. Okomato Y, Shibazaki K, Minami S, Matsuhashi A, Tanioka S, Shigemasa Y. Evaluation of chitin and chitosan on open wound healing in dogs. J Vet Med Sci 1995;57:851-854.
37. Şenel S, İkinci G, Yousefi-Rad A, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oramucosal drug delivery. Int J Pharm 2000;193:197-203.
38. Lee YM, Park YJ, Lee SJ, Ku Y, Han SB, Klokkevold PR, Chung CP. The bone regenerative effect of platelet derived growth factor-bb delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol 2000;71:418-424.
39. Muzzarelli RAA, Biagini G, Pugnaloni A, Filippini O, Baldassarre V, Castaldini C, Rizzoli C. Reconstruction of paradontal tissue with chitosan. Biomaterials 1989;10:598-603.
40. Mitchell DA. Metronidazole: Its use in clinical dentistry. J Clin Periodontol 1984;11:145-158.
41. Greenstein G. The role of metronidazole in the treatment of periodontal diseases. J Periodontol 1993;64:1-15.
42. Jenkins WMM, MacFarlane TM, Gilmour WN, Ransay I, Mackenzie D. Systemic metronidazole in the treatment of periodontitis. J Clin Periodontol 1989;16:443-450.
43. Loeshe WJ, Giordano JR, Hujoel P, Schwarez J, Smith BA. Metronidazole in periodontitis: Reduced need for surgery. J Clin Periodontol 1992;19:103-112.
44. Lindhe J, Liljenberg B, Adielson B, Borjesson I. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 1983;10:100-112.
45. Klinge B, Attström R, Karring T, Kisch J, Lewin B, Stoltze K. Three regimens of topical metronidazole compared with subgingival scaling on periodontal pathology in adults. J Clin Periodontol 1992;19:708-714.
46. Klinge B, Kuvatanasuhati J, Attström R, Kalfas S. The effect of topical metronidazole therapy on experimentally-induced periodontitis in the Beagle dog. J Clin Periodontol 1992;19:702-707.
47. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
48. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalance and severity. Acta Odontol Scand 1963;21:533-551.
49. Nowicki D, Vogel RI, Melcher S, Deasy MJ. The gingival bleeding time index. J Clin Periodontol 1981;52:260-262.
50. Yun YS, Kim KS, Lee YN. Antibacterial and antifungal effect of chitosan. J Chitin Chitosan 1999;4:8-14.
51. Şenel S, Kaş HS, Squier CA. Application of chitosan in dental drug delivery and therapy. In: Muzzarelli, RAA, editor. Chitosan Per os: From dietary supplement to drug carrier. Grottammare: Atec; 2000. pp 241-256.
52. Goodson JM, Hogan PE, Dunham SI. Clinical responses following periodontal treatment by local drug delivery. J Clin Periodontol 1985;11:81-87.
53. Fakhry A, Schneider GB, Zaharias R, Şenel S. Chitosan supports the initial attachment and spreading of osteoblasts, preferentially over fibroblasts. Biomaterials 2004;25:2075-2079.
54. Aksungur P, Sungur A, Ünal S, Iskit AB, Squier CA, Şenel S. Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies. J Controlled Release 2004;98:269-279.
55. Duman SS, Korkusuz P, Bilgili H, Hincal AA, Senel S. Chitosan and alginate scaffolds for tissue regeneration. Presented at the 6th International Conference of European Chitin Society (EUCHIS 2004), Poznan, Poland, September, 2004.
56. Ainamo J, Lie T, Ellingsen BH, Hansen BF, Johansson L-Å, Karring T, Kisch J, Paunio K, Stoltze K. Clinical responses to subgingival application of metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 1992;19:723-729.
57. Noyan Ü, Yilmaz S, Kuru B, Kadir T, Acar O, Büget E. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 1997;24:158-165.
58. Pedrazzoli V, Kilian M, Karring T. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis. J Clin Periodontol 1992;19:715-722.
59. Tonetti MS. The topical use of antibiotics in periodontal pockets. In: Lang NP, Karring T, Lindhe J, editors. Proceedings of the second European workshop on periodontology. Berlin: Quintessence Verlag; 1996. pp 78-109.
60. Stetzel M, Florés-De-Jacoby L. Topical metronidazole application compared with subgingival scaling. A clinical and microbiological study on recall patients. J Clin Periodontol 1996;23:24-29.